Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 30;16(2):234-243.
doi: 10.15283/ijsc22171. Epub 2023 Feb 28.

Transition Substitution of Desired Bases in Human Pluripotent Stem Cells with Base Editors: A Step-by-Step Guide

Affiliations

Transition Substitution of Desired Bases in Human Pluripotent Stem Cells with Base Editors: A Step-by-Step Guide

Ju-Chan Park et al. Int J Stem Cells. .

Abstract

The recent advances in human pluripotent stem cells (hPSCs) enable to precisely edit the desired bases in hPSCs to be used for the establishment of isogenic disease models and autologous ex vivo cell therapy. The knock-in approach based on the homologous directed repair with Cas9 endonuclease, causing DNA double-strand breaks (DSBs), produces not only insertion and deletion (indel) mutations but also deleterious large deletions. On the contrary, due to the lack of Cas9 endonuclease activity, base editors (BEs) such as adenine base editor (ABE) and cytosine base editor (CBE) allow precise base substitution by conjugated deaminase activity, free from DSB formation. Despite the limitation of BEs in transition substitution, precise base editing by BEs with no massive off-targets is suggested to be a prospective alternative in hPSCs for clinical applications. Considering the unique cellular characteristics of hPSCs, a few points should be considered. Herein, we describe an updated and optimized protocol for base editing in hPSCs. We also describe an improved methodology for CBE-based C to T substitutions, which are generally lower than A to G substitutions in hPSCs.

Keywords: Base editors; Cas9; Genome editing; Human pluripotent stem cells; Transition substitution.

PubMed Disclaimer

Conflict of interest statement

Potential Conflict of Interest

The authors have no conflicting financial interest.

Figures

Fig. 1
Fig. 1
Composition and mechanisms of ABE8e and AncBE4max. Graphical scheme for composition and mechanisms of (A) ABE8e and (B) AncBE4max, Red box indicates editing window, bases, colored in blue indicates spacer sequence, PAM sequence is colored in red, and the target base for each base editor is colored in yellow. Number indicates the position in the spacer sequence. A for Adenine, I for Inosine, G for Guanine, C for Cytosine, U for Uracil land T for Thymine. Created with BioRender.com.
Fig. 2
Fig. 2
Role of DNA replication, mismatch repair, base excision repair and UNG in C to T conversion. (i) Nickase activity of nCas9 in CBE induces nick on the editing strand and deaminase activity in CBE produces G:U mismatch. G:U mismatch is converted to A:T via DNA replication followed by mismatch repair. (ii) Alternatively, G:U mismatch, recognized by base excision repair (BER), is removed by UNG to produce AP site, forming G:C. (iii) UNG activity to impair the G-to-A substitution is the co-expression of UNG inhibitor (UGI). Created with BioRender.com.
Fig. 3
Fig. 3
PAM requirement for base editing. (A) Graphical scheme for editing window of BEs, Red box indicates editing window. ‘x’ and ‘y’ indicates start and end position of editing window respectively. (B) Target base is colored in red and PAM sequence is colored in brown. Graphical scheme of PAM requirement for, (C) ABE8e, (D) YE1-BE4max, (E) NG-ABE8e, and (F) YE1-BE4max-NG. Target base is colored in red and PAM sequence is colored in brown. Created with BioRender.com.
Fig. 4
Fig. 4
Bystander base editing of AncBE4max. (A) Graphical scheme for the bystander base in the editing window (colored in red) and possible outcomes. (B) Sequences of GNE encoding 329 isoleucine (329I) in WT hESCs (i), GNE mutants hESCs after ABE application (ii), isolated hESCs with I329I silence mutation due to bystander editing (blue arrow) and GNE mutant hESCs with I329T mutation from target base edit (red arrow) (C) Graphical scheme for GNE mutant hPSCs, WT (blue), I329I mutant (red), and I329T mutant hESCs (green). Created with BioRender.com.

References

    1. Merkle FT, Eggan K. Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell. 2013;12:656–668. doi: 10.1016/j.stem.2013.05.016. - DOI - PubMed
    1. Musunuru K. Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech. 2013;6:896–904. doi: 10.1242/dmm.012054.0597c183c52c4f5399dcbb9af1a35746 - DOI - PMC - PubMed
    1. Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27:523–531. doi: 10.1016/j.stem.2020.09.014. - DOI - PubMed
    1. Rowe RG, Daley GQ. Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet. 2019;20:377–388. doi: 10.1038/s41576-019-0100-z. - DOI - PMC - PubMed
    1. Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38:824–844. doi: 10.1038/s41587-020-0561-9. - DOI - PubMed

LinkOut - more resources